CAPR · Capricor Therapeutics, Inc.

Summary

Capricor Therapeutics, Inc. furnished its Fourth Quarter and Full Year 2025 results via Exhibit 99.1 press release under Item 2.02. This disclosure provides investors with the company's financial performance for the reported periods.

Key takeaways

• Form 8-K filed on 2026-03-12
• Item 2.02: Results of Operations disclosed
• Item 9.01: Financial Statements and Exhibits
• Exhibit 99.1: Press Release titled “Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Pr”
• Furnished, not filed for Section 18 purposes